Ascent Group LLC Sells 466 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ascent Group LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,098 shares of the medical equipment provider’s stock after selling 466 shares during the quarter. Ascent Group LLC’s holdings in Intuitive Surgical were worth $1,378,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth about $26,000. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. Delos Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on ISRG shares. Piper Sandler upped their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Citigroup upped their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research report on Monday, July 15th. Finally, Truist Financial upped their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Stock Up 2.5 %

ISRG opened at $491.27 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.18. The stock has a market cap of $174.25 billion, a price-to-earnings ratio of 88.68, a PEG ratio of 5.39 and a beta of 1.39. The business has a 50 day moving average of $473.63 and a 200-day moving average of $429.56.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period last year, the firm posted $1.18 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Insider Activity

In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $446.60, for a total transaction of $167,921.60. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,458,979.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock valued at $25,528,753 over the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.